Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using a combined treatment of minoxidil and metformin can improve hair loss in women by normalizing hormone and metabolism levels.

Preventing childhood obesity can reduce the risk of developing polycystic ovary syndrome in adolescents.

Hormone levels in women with androgenetic alopecia are similar to those without the condition.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Hormonal dysfunctions, like PCOS, are common among reproductive-age women in India.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

More research is needed to understand the long-term benefits of insulin-sensitizing drugs for treating adolescents with PCOS.

Inhaled substances in e-cigarettes can cause hormone imbalances similar to congenital adrenal hyperplasia.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Removing both ovaries treated the woman's excess male hormone symptoms.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Resveratrol improved menstrual regularity and reduced hair loss in women with PCOS.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.